Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Julius

Showing results (111-120 of 115) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 115 results.
Atherosclerosis. Supplements|May 5, 2015
TIDILAP: Treatment of iron deficiency in lipoprotein apheresis patients --A prospective observational multi-center cohort study comparing efficacy, safety and tolerability of ferric gluconate with ferric carboxymaltoseU Schatz, B M W Illigens, T Siepmann, et al.
Atherosclerosis. Supplements|November 4, 2017
Lipoprotein apheresis influences monocyte subpopulationsS Jellinghaus, C Reich, U Schatz, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|May 11, 2022
Correction: Precision Medicine Approach for Cardiometabolic Risk Factors in Therapeutic ApheresisX Yin, K Takov, R Straube, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|April 12, 2022
Precision Medicine Approach for Cardiometabolic Risk Factors in Therapeutic ApheresisX Yin, K Takov, R Straube, et al.
Atherosclerosis|September 29, 2024
The German Lipoprotein Apheresis Registry-Summary of the eleventh annual reportV J J Schettler, N Selke, S Jenke, et al.
Pageof 12

Showing results (111-120 of 115) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 115 results.
Atherosclerosis. Supplements|May 5, 2015
TIDILAP: Treatment of iron deficiency in lipoprotein apheresis patients --A prospective observational multi-center cohort study comparing efficacy, safety and tolerability of ferric gluconate with ferric carboxymaltoseU Schatz, B M W Illigens, T Siepmann, et al.
Atherosclerosis. Supplements|November 4, 2017
Lipoprotein apheresis influences monocyte subpopulationsS Jellinghaus, C Reich, U Schatz, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|May 11, 2022
Correction: Precision Medicine Approach for Cardiometabolic Risk Factors in Therapeutic ApheresisX Yin, K Takov, R Straube, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|April 12, 2022
Precision Medicine Approach for Cardiometabolic Risk Factors in Therapeutic ApheresisX Yin, K Takov, R Straube, et al.
Atherosclerosis|September 29, 2024
The German Lipoprotein Apheresis Registry-Summary of the eleventh annual reportV J J Schettler, N Selke, S Jenke, et al.
Pageof 12